Abstract 3715: EP-100 syndergizes with paclitaxel in ovarian, breast and prostate cancer cell lines

Author(s):  
Carola Leuschner ◽  
Cody Giardina ◽  
Hector W. Alila
2002 ◽  
Vol 317 (1-2) ◽  
pp. 17-26 ◽  
Author(s):  
Rachel S Rosenberg Zand ◽  
David J.A Jenkins ◽  
Theodore J Brown ◽  
Eleftherios P Diamandis

2009 ◽  
Vol 52 (15) ◽  
pp. 4964-4967 ◽  
Author(s):  
Damian Plażuk ◽  
Anne Vessières ◽  
Elizabeth A. Hillard ◽  
Olivier Buriez ◽  
Eric Labbé ◽  
...  

Metabolites ◽  
2019 ◽  
Vol 9 (11) ◽  
pp. 281 ◽  
Author(s):  
Schepkens ◽  
Dallons ◽  
Dehairs ◽  
Talebi ◽  
Jeandriens ◽  
...  

In this study, metastatic melanoma, breast, and prostate cancer cell lines were analyzed using a 1H-NMR-based approach in order to investigate common features and differences of aggressive cancers metabolomes. For that purpose, 1H-NMR spectra of both cellular extracts and culture media were combined with multivariate data analysis, bringing to light no less than 20 discriminant metabolites able to separate the metastatic metabolomes. The supervised approach succeeded in classifying the metastatic cell lines depending on their glucose metabolism, more glycolysis-oriented in the BRAF proto-oncogene mutated cell lines compared to the others. Other adaptive metabolic features also contributed to the classification, such as the increased total choline content (tCho), UDP-GlcNAc detection, and various changes in the glucose-related metabolites tree, giving additional information about the metastatic metabolome status and direction. Finally, common metabolic features detected via 1H-NMR in the studied cancer cell lines are discussed, identifying the glycolytic pathway, Kennedy’s pathway, and the glutaminolysis as potential and common targets in metastasis, opening up new avenues to cure cancer.


Sign in / Sign up

Export Citation Format

Share Document